ELAN

ELAN

USD

Elanco Animal Health Incorporated Common Stock

$22.500+0.270 (1.215%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$22.230

High

$22.840

Low

$22.150

Volume

12.80M

Company Fundamentals

Market Cap

11.2B

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

7.18M

Exchange

NYQ

Currency

USD

52-Week Range

Low $8.02Current $22.500High $22.96

Related News

PR Newswire

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Elanco Animal Health Incorporated (NYSE: ELAN) today announced label expansions for two of its leading canine prescription parasiticides, Credelio...

View more
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
PR Newswire

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...

View more
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
Analyst Upgrades

JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24

JP Morgan analyst Chris Schott upgrades Elanco Animal Health from Neutral to Overweight and raises the price target from $18 to $24.

View more
JP Morgan Upgrades Elanco Animal Health to Overweight, Raises Price Target to $24